Table of Contents
As the 118th Congress approaches its post-election "lame duck" session, the National Association of Chain Drug Stores is ramping up its call for bipartisan action on PBM reform. The organization emphasizes the critical need to reduce prescription drug costs, protect Americans' access to trusted pharmacies and essential medications, and prevent forced pharmacy closures.
CDR
A recent NACDS poll by Morning Consult highlights strong voter support for reform. More than two-thirds (69%) of registered voters believe PBM reform should be classified as "must-pass legislation" before Congress concludes its work in 2024. The survey also reveals that health care issues significantly influenced voters' decisions in the 2024 elections:
- 88% prioritized access to health care.
- 88% highlighted the affordability of health care.
- 87% pointed to prescription drug prices as critical concerns.
- 87% emphasized the ability of patients to choose their health care providers.
PBMs, intermediaries between insurers, pharmacies and drug manufacturers, have faced criticism for practices that inflate drug prices and restrict pharmacy access. NACDS has stressed that these practices harm patients and threaten the survival of independent pharmacies.
"Congress must seize this moment to enact meaningful PBM reform," said NACDS in a statement. "The American public has made their voices clear: Addressing PBM abuses is essential to ensuring fair and affordable health care for all."
Reform efforts aim to increase transparency, eliminate anti-competitive practices, and provide relief to patients and pharmacies alike. With overwhelming voter support and pressing concerns about rising drug costs, NACDS urges lawmakers to prioritize this issue in the legislative session's final days.
CDR
